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Abstract
Background: The tongue squamous cell carcinomas (SCCs) are characterized by high mitotic
activity, and early detection is desirable. Overexpression of the DNA replication-initiation proteins
has been associated with dysplasia and malignancy. Our aim was to determine whether these
proteins are useful biomarkers for assessing the development of tongue SCC.
Methods: We analyzed the mRNA expression of CDC6, CDT1, MCM2 and CDC45 in formalin-
fixed, paraffin-embedded benign and malignant tongue tissues using quantitative real-time PCR
followed by statistical analysis.
Results: We found that the expression levels are significantly higher in malignant SCC than mild
precancerous epithelial dysplasia, and the expression levels in general increase with increasing
grade of precancerous lesions from mild, moderate to severe epithelial dysplasia. CDC6 and
CDC45 expression is dependent of the dysplasia grade and lymph node status. CDT1 expression
is higher in severe dysplasia than in mild and moderate dysplasia. MCM2 expression is dependent
of the dysplasia grade, lymph node status and clinical stage. The expression of the four genes is
independent of tumor size or histological grade. A simple linear regression analysis revealed a linear
increase in the mRNA levels of the four genes from the mild to severe dysplasia and SCC. A strong
association was established between CDC6 and CDT1, and between MCM2 and CDC45
expression. The nonparametric receiver operating characteristic analysis suggested that MCM2 and
CDC45 had a higher accuracy than CDC6 and CDT1 for distinguishing dysplasia from tongue SCC.
Conclusion: These proteins can be used as biomarkers to distinguish precancerous dysplasia from
SCC and are useful for early detection and diagnosis of SCC as an adjunct to clinicopathological
parameters.
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Background
In eukaryotic cells, precise DNA replication is accom-
plished by licensing and activation of replication origins
so that the genome is duplicated exactly once per cell cycle
[1]. The cis-acting replicators are recognized by origin rec-
ognition complex (ORC), which recruits the loading fac-
tors, NOC3 [2], CDC6 and CDT1, thereby promoting the
loading of the hexameric minichromosome maintenance
(MCM) protein complex onto replicators, forming the
pre-replication complex (pre-RC). In late G1 phase, CDC6
and CDT1 are dissociated from replicators and replaced
by CDC45, forming the pre-initiation complex (pre-IC).
As cells progress through S phase, MCM and CDC45 are
displaced from the chromatin, leaving ORC and NOC3
on the replicators to form the post-replication complex
(post-RC) [1,2]. Deregulation of the expression of DNA
replication-initiation proteins results in genomic instabil-
ity and contributes to the malignant transformation of
cells [3].
In an adult human body, the vast majority of the cells has
differentiated and ceased cell division, and only a small
population of cells is proliferating in some self-renewing
tissues. Some DNA replication-initiation proteins are
expressed only in malignant and precancerous cells but
not in nonproliferating, differentiated and replicative
senescent human cells [4]. Therefore, the members of the
DNA replication-initiation proteins are excellent biomar-
kers for cell proliferation [5-8] and targets for anticancer
drugs [9].
More than 50% of head and neck cancers arise from the
oral cavity, of which over 90% are squamous cell carcino-
mas (SCCs), with the majority representing SCC of the
tongue [10]. Many oral carcinomas had pre-cancerous
lesions including dysplasia. Although the oral cavity is
easily accessible for clinical examination and biopsies,
precancerous lesions are often missed, and oral cancers
are usually diagnosed at late stages. Therefore, many
patients still face poor prognosis. Currently only the gold
standard of histological examination of a scalpel biopsy
or surgical specimen can provide a definitive diagnosis.
Early detection would offer better treatment, increased
survival, and improved quality of life with reduced need
for aggressive treatments or disfiguring surgery.
Studies in the last decade have demonstrated some of the
most frequent molecular changes found in oral cancers,
such as P53, P16, Cyclin D1, Ki67, and PCNA by using
immunohistochemistry [11,12]. Since aberrant overex-
pression of the replication initiation machinery is found
in many types of cancers, CDC6, CDT1, MCM2 and
CDC45 may also be useful markers for assessing the type
and degree of oral pre-malignant as well as malignant
lesions. The purpose of the present study was to test the
hypothesis that DNA replication-initiation proteins are
useful biomarkers for early detection and diagnosis of
SCC of the tongue and to elucidate the relationship
between the expression of replication-initiation proteins
and clinical characteristics using quantitative real-time
PCR (QRT-PCR) assays. In addition, we assessed the cor-
relation between the expression level of CDC6 and CDT1,
and between CDC45 and MCM2 in SCC of the tongue.
Methods
Patient tissue specimens
Sixty-four patients with a median age of 54 years (range,
17 to 82 years) with SCC of the tongue who had surgery
from August 2004 to July 2007 at the First Affiliated Hos-
pital, Sun Yat-sen University, Guangzhou, China were
included in this analysis. This study was approved by the
Medical Ethical Committee of the First Affiliated Hospital,
Sun Yat-sen University. All tumors were classified accord-
ing to the standard of the American Joint Committee on
Cancer (AJCC). Thirty-one epithelial dysplasia samples
were used as the precancerous specimens, including 8 of
mild epithelial dysplasia, 8 of moderate epithelial dyspla-
sia and 15 of severe epithelial dysplasia. Histological
grade, tumor stage and tumor size were examined and
classified according to the International Union Against
Cancer (UICC) scheme. All of the sites of distant metas-
tases (M) were lymph nodes. The stage of primary carci-
noma and patient characteristics are listed in Table 1. The
surrounding normal tissues including stromal cells were
largely removed from the surgical samples based on the
gross morphology before formalin-fixation and paraffin-
embedding. Serial section slices were then obtained, and
some of the slices were used for pathological diagnosis
microscopically by two pathologists after hematoxylin
and eosin staining, while some other slices were used for
QRT-PCR.
Extraction of RNA from formalin-fixed, paraffin-
embedded tissues
Total RNA was extracted from the formalin-fixed, paraffin-
embedded specimens as described [13]. Briefly, five to ten
6-μm sections were deparaffinized twice by addition of 1
ml of xylene and incubating at 55°C for 10 min, and
dehydrated by subsequent washes with 100, 90 and 70%
ethanol in RNase-free water. The pellet was then air-dried
at room temperature, resuspended in 200 μl of RNA lysis
buffer containing 20 mM Tris/HCL (pH 7.6), 20 mM eth-
ylenediaminetetraacetic acid (pH 8.0), 2% sodium
dodecyl sulfate (pH 7.2), and 500 μg/ml proteinase K, and
incubated at 55°C for 16 hrs to dissolve the tissue. RNA
was purified from the digested tissue using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) according to the manu-
facturer's instructions. The RNA pellet was washed with
70% ethanol, air-dried, resuspended in 30–50 μl ofBMC Cancer 2008, 8:395 http://www.biomedcentral.com/1471-2407/8/395
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RNase-free water, incubated at 55°C for 10 min, and
stored at -80°C until use.
Reverse transcription
RNA was reverse transcribed using First Strand cDNA Syn-
thesis Kit (MBI Fermentas, Vilnius, lithuania) according to
the manufacturer's introductions. In brief, 100 ng of total
RNA, 1 μl of oligo(dT)18 primer (0.5 μg/μl) and DEPC-
treated water in a final volume of 20 μl were mixed, incu-
bated at 70°C for 5 minutes, and then chilled on ice. Four
microliters of 5× Reaction buffer, 1 μl of ribonuclease
inhibitor (20 IU) and 2 μl of 10-mM dNTP were added,
and the tube was incubated at 37°C for 5 min. An addi-
tional 200 units of reverse transcriptase was added and
incubated at 37°C for 60 min. The reaction was stopped
by heating at 70°C for 10 min. The cDNA samples were
stored at -20°C until use.
Quantitative real-time PCR
Quantitative PCR was performed with the real-time PCR
system, iQ™ 5 (Bio-Rad, Hercules, CA, USA), using SYBR
Green I double strand DNA binding dye. The intron-span-
ning primers used for real-time PCR were designed to
meet the specificity criteria using Oligo 6.0 software. The
sequences of the PCR primer pairs and amplicon size of
the selected genes are shown in Table 2.
The PCR mixture was prepared using the SYBR Green I
Premix Ex Taq kit (TaKaRa Biomedical, Kusatsu, Japan) in
a total volume of 20 ul containing 0.2 μmol of each
primer, 10 μl of 2× SYBR Green I Premix Ex Taq, and 2 μl
of cDNA. The reactions were performed in 8-well PCR
strip tubes with flat caps. The initial template denatura-
tion was at 95°C for 10 sec, followed by 45 two-step cycles
of 5 sec at 95°C and then annealing and extension at
60°C for 20 sec. Fluorescence data were collected after
each extension step. Melting curve analysis was performed
to confirm the amplification specificity by heating the
template over a 35°C temperature gradient at 0.5°C/sec
from 60 to 95°C while continuously monitoring the flu-
orescence.
To demonstrate the linearity and efficiency and for the
purpose of quantification, standard curves were gener-
ated. The housekeeping gene β-actin was used as the inter-
nal control. Gene specific PCR products were purified
Table 1: Clinicopathological parameters and mRNA expression in the patients (n = 64)
Characteristic No.(%) CDC6 CDT1 MCM2 CDC45
Age (years)
Median 54 (range 17–82)
Sex
Male 33(52%) 2.17E-03 ± 8.24E-04 1.10 ± 0.44 1.20 ± 0.24 2.17 ± 0.41
Female 31(48%) 6.28E-03 ± 1.97E-03 1.04 ± 0.34 1.28 ± 0.29 2.67 ± 0.89
Epithelial dysplasia (precancerous, n = 31)
Mild 8(26%) 4.68E-04 ± 1.42E-04 0.64 ± 0.14 0.19 ± 0.05 0.35 ± 0.72
Moderate 8(26%) 6.59E-03 ± 3.20E-03 0.99 ± 0.20 1.03 ± 0.18 2.29 ± 0.85
Severe 15(48%) 8.28E-03 ± 3.40E-03 1.94 ± 0.36 2.48 ± 0.35 3.32 ± 0.54
Histological grade (SCC, n = 33)
G1 13(40%) 6.87E-03 ± 2.67E-03 0.92 ± 0.19 1.15 ± 0.22 2.48 ± 0.82
G2 10(30%) 7.87E-03 ± 6.51E-04 0.72 ± 0.17 0.99 ± 0.30 1.97 ± 0.59
G3 10(30%) 8.61E-03 ± 1.30E-03 1.40 ± 0.30 1.73 ± 0.73 2.45 ± 0.13
T-stage
T1 10(34%) 7.61E-03 ± 4.45E-03 1.01 ± 0.27 0.71 ± 0.20 3.17 ± 0.93
T2 19(66%) 5.02E-03 ± 7.62E-04 0.94 ± 0.14 1.56 ± 0.42 1.57 ± 0.44
Lymph node metastases
N0 12(41%) 6.11E-04 ± 1.66E-04 0.74 ± 0.16 0.60 ± 0.15 1.27 ± 0.35
N1 11(38%) 3.50E-03 ± 1.02E-03 0.90 ± 0.15 1.03 ± 0.64 2.00 ± 0.52
N2 6(21%) 1.02E-02 ± 7.03E-03 1.28 ± 0.28 2.00 ± 0.42 3.54 ± 0.15
Clinical stage
I 4(13%) 4.21E-04 ± 3.08E-04 0.89 ± 0.14 0.15 ± 0.04 1.13 ± 0.36
II 8(28%) 8.02E-04 ± 1.13E-04 0.74 ± 0.16 0.85 ± 0.21 1.55 ± 0.46
III 11(38%) 3.50E-03 ± 1.02E-03 1.07 ± 0.28 1.03 ± 0.64 2.01 ± 0.52
IV 6(21%) 1.02E-02 ± 7.03E-03 1.78 ± 0.82 2.00 ± 0.42 3.54 ± 0.15
T-stage (tumor size): Tl, < 2 cm; T2, 2 to 4 cm; T3 > 4 cm
G1, highly differentiated; G2, moderately differentiated; G3, poorly differentiated
Stage I, T1N0M0; stage II, T2N0M0; stage III, T3N0M0, T1-3N1-2M0; stage IV, T4N0-3M0
Shown is quantitative gene expression analysis by QRT-PCR in different formalin-fixed, paraffin-embedded specimens. Levels of CDC6, CDT1, 
MCM2 and CDC45 mRNA were determined by QRT-PCR and all measurements are shown relative to the expression levels of the β-actin 
housekeeping gene. Shown are the mean normalized values of three independent experiments, each in duplicates, using different cDNA samples.BMC Cancer 2008, 8:395 http://www.biomedcentral.com/1471-2407/8/395
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using a DNA extraction kit (MBI Ferments), quantified
spectrophotometrically, and cloned into pMD18-T vector
(TaKaRa). The sequences of the target genes were verified
by DNA sequencing. Standard curves for β-actin, CDC6,
CDT1, MCM2 and CDC45 were generated by performing
serial dilutions (102–106 copies) of the plasmids contain-
ing the target genes and amplifying them in every PCR run
with the patient samples.
The relative expression level of the gene of interest in the
patient samples was computed with respect to the internal
standard. The normalized expression level of the target
gene as obtained as follows: target copy number/β-actin
copy number. Each sample was tested in duplicate, and
each experiment was repeated at least twice using cDNA
samples from separate reverse transcriptions. The gener-
ated data were averaged and expressed in relative units of
normalized expression.
Statistical analysis
One-Way ANOVA test and Kruskal-Wallis H test were
used to determine differences in normalized mRNA
expression levels between the precancerous and different
squamous cell carcinoma clinicopathological parameters.
The Mann-Whitney U test was used to assess pair-wise dif-
ferences between the two cohort groups. A simple regres-
sion analysis was used to determine the relationship
between the mRNA expression of different genes and the
established clinicopathological parameters. Receiver
operating characteristic (ROC) curves and the areas under
the curves (AUC) were calculated to assess the accuracy of
the tests. Differences between the areas under the curves
were tested for statistical significance based on the esti-
mated areas and their standard errors. A p value < 0.05 was
considered statistically significant. Statistical analysis of
results was carried out using SPSS v11.0 software.
Results
The mRNA levels of CDC6, CDT1, MCM2 and CDC45 in
31 cases of precancerous epithelial dysplasia and 33 cases
of squamous cell carcinoma of the tongue from formalin-
fixed, paraffin-embedded specimens were measured using
QRT-PCR. The level of the target mRNA was normalized
to the amount of β-actin mRNA in the same sample.
Standard curves for β-actin and the target genes were
shown in Figure 1. The linearity of the plots shows that the
coefficient of correlation for all five genes was very high
(R2 > 0.994). The resultant target mRNA/β-actin ratio
showed the normalized expression of the target gene. The
normalized expression values and pathological variables
are shown in Table 1.
CDC6 quantitative real-time PCR analysis
Real-time PCR for CDC6 revealed that there was statisti-
cally significant overall difference in CDC6 expression
among the mild, moderate and severe epithelial dysplasia
Table 2: Primer sequences and amplicon size of the genes analyzed by QRT-PCR
Gene name Accession No. Primer sequence Amplicon size
-ACTIN NM_001101.2 F: 5'-ATCCAGGCTGTGCTATCC-3' 105 bp
R: 5'-GGCATACCCCTCGTAGAT-3'
CDC6 U77949.1 F: 5'-TGTCAAAAGCCAGACTAT-3' 88 bp
R: 5'-GTGAATAAGACCAACCCT-3'
CDC45 AF053074.1 F: 5'-TGGACTGCACACGGATCT-3' 106 bp
R: 5'-AACCTGGCTGCGGTATAG-3'
MCM2 NM_004526.2 F: 5'-AGGCAGCATCCCCATTAC-3' 89 bp
R: 5'-TCACATAGTCCCGCAGAT-3'
CDT1 NM_030928.2 F: 5'-ATCCGCACCGACACCTAC-3' 135 bp
R: 5'-TCTGAAGCCCACGTCTGT-3'
CDC6, CDT1, MCM2, CDC45 and β-actin standard curves Figure 1
CDC6, CDT1, MCM2, CDC45 and β-actin standard 
curves. SYBR GREEN I standard curves for CDC6, CDT1, 
MCM2, CDC45 and β-actin were obtained by amplifying five 
serial dilutions of standards known concentration (102–106). 
The linearity of the plots shows the coefficient of correlation 
for five genes. R2 > 0.994.BMC Cancer 2008, 8:395 http://www.biomedcentral.com/1471-2407/8/395
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and SCC of the tongue (p = 0.043; Kruskal-Wallis test)
(Table 1; Figure 2A). In addition, the mean level of CDC6
was markedly higher in SCC of the tongue and severe epi-
thelial dysplasia than in the mild epithelial dysplasia (p =
0.02 and 0.008, respectively; Mann-Whitney test). How-
ever, a statistically significant difference in CDC6 expres-
sion was not observed between the mild and moderate
epithelial dysplasia (p = 0.912), between moderate and
severe epithelial dysplasia (P = 0.451), between moderate
epithelial dysplasia and SCC (p  = 0.311), or between
severe epithelial dysplasia and SCC (p = 0.728). Although
the CDC6 mRNA increased with increasing grades of the
clinicopathological classifications (except for the T-stage)
of SCC, the Kruskal-Wallis test did not reveal statistically
significant overall correlation of CDC6 mRNA level with
tumor size (P = 0.159), lymph node status (p = 0.145),
clinical stage (p = 0.242) or histological grade (p = 0.052).
However, when using the Mann-Whitney test to assess
pair-wise differences within each SCC classification
group, statistically significant difference was found for N0
and N1 (p = 0.042), and for N0 and N2 (p = 0.031). These
results showed that CDC6 mRNA was up-regulated during
the malignant process of the tongue SCC.
CDT1 quantitative real-time PCR analysis
There was statistically significant overall difference in
CDT1 expression among the different epithelial dysplasia
groups and SCC of the tongue (p = 0.034; Kruskal-Wallis
test) (Table 1; Figure 2B). CDT1 mRNA expression levels
were significantly higher in severe epithelial dysplasia
than in mild epithelial dysplasia (p = 0.006), moderate
epithelial dysplasia (p  = 0.034), and SCC (p = 0.019).
However, the differences between mild epithelial dyspla-
sia and SCC (p = 0.202) and between moderate epithelial
dysplasia and SCC (p = 0.72) did not reach statistically sig-
nificant levels. Like CDC6, the ANOVA test revealed that
there was no statistically significant overall correlation of
CDT1 mRNA level with tumor size (p = 0.43), lymph node
status (p = 0.200), clinical stage (p = 0.221) or histological
grade (p = 0.215). With the advancement in the clinical
stage and lymph node status of the SCC, CDT1 mRNA
increased, but not to a statistically significant level of dif-
ference.
MCM2 quantitative real-time PCR analysis
The overall difference in MCM2 mRNA expression among
the different grades of the precancerous epithelia dyspla-
sia and SCC of the tongue is highly statistically significant
(p  = 0.000; Kruskal-Wallis test) (Table 1; Figure 2C).
MCM2 mRNA levels were significantly higher in SCC than
in mild epithelia dysplasia (p = 0.000). In addition, the
MCM2 expression level increased with increasing grade of
dysplasia, with a highly significant difference between the
mild and moderate epithelial dysplasia (p  < 0.001),
between the mild and severe epithelial dysplasia (p  =
0.000), and between the moderate and severe epithelial
dysplasia (p < 0.001). However, a statistically significant
difference in MCM2 mRNA level was not observed
between the moderate epithelial dysplasia and SCC (p =
0.35). The Kruskal-Wallis test revealed that there were sta-
tistically significant overall correlation of MCM2 levels
with lymph node status (p = 0.007) and clinical stage (p =
0.002), but not with histological grade (p  = 0.84) or
tumor size (p = 0.127). When using the Mann-Whitney U-
test to assess pair-wise differences within each SCC classi-
fication group, a statistically significant difference was
observed between N0 and N2 (p = 0.006), N1 and N2 (p
= 0.012), I and IV (p < 0.0001), I and III (p = 0.019), but
not between N0 and N1 (p = 0.455), or II and III (p =
0.612).
CDC45 quantitative real-time PCR analysis
The relationship between CDC45 mRNA and pathologi-
cal variables is shown in Figure 2D. CDC45 mRNA level
was significant lower in mild epithelial dysplasia than in
the moderate epithelial dysplasia, severe epithelial dyspla-
sia, and SCC (p = 0.008, < 0.001, and 0.026, respectively;
Mann-Whitney test). The ANOVA F test revealed that there
was no statistically significant overall correlation of
CDC45 mRNA expression with tumor size (p = 0.085) or
histological grade (p = 0.887). The P value for the lymph
node status and clinical stage was 0.348 and 0.524,
Box plots for the normalized expression levels of CDC6 (A),  CDT1 (B), MCM2 (C) and CDC45 (D) in mild, moderate and  severe epithelial dysplasia and tongue SCC Figure 2
Box plots for the normalized expression levels of 
CDC6 (A), CDT1 (B), MCM2 (C) and CDC45 (D) in 
mild, moderate and severe epithelial dysplasia and 
tongue SCC. The box represents 50% quartiles (above 25% 
and below 75%) and the solid line within each box is the 
median gene expression value. The small circles represent 
the outliers.BMC Cancer 2008, 8:395 http://www.biomedcentral.com/1471-2407/8/395
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respectively, by using the Kruskal-Wallis test to analyze
the overall correlation of CDC45 with these clinical
parameters. When using the Mann-Whitney U-test to
assess pair-wise differences within each SCC classification
group, there was a statistically significant difference
between N1 and N2 (p = 0.018), and between N0 and N2
(p = 0.004).
Relationship of the expression of replication-initiation 
proteins with established clinicopathological parameters
Table 3 depicts the relationship between the target gene
expression and the established clinicopathological
parameters. Significant correlations were observed for
CDC6 (r = 0.323, p = 0.027), CDT1 (r = 0.538, p = 0.000),
MCM2 (r = 0.592, p = 0.000) and CDC45 (r = 0.451, p =
0.001). We also used a simple linear regression analysis to
assess the pair-wise relationship of different marker genes.
Analysis revealed a highly significant linear relationship
between CDC6 and CDT1 expression (r = 0.415, p  =
0.013) (Figure 3A). In addition, a strong association was
established between MCM2 and CDC45 expression (r =
0.244, p = 0.037) (Fig. 3B). But there were no correlation
between other pair-wise genes (data not shown).
Diagnostic accuracy of CDC6, CDT1, MCM2 and CDC45 
mRNA expression levels
The receiver operating characteristic (ROC) curves of
CDC6, CDT1, MCM2 and CDC45 were used to analyze
the diagnostic accuracy based on the gene expression
measured by QRT-PCR (Figure 4). The area under the
ROC curve (AUC) was 0.679 for CDC6 (p = 0.032), 0.808
for CDT1 (p = 0.000), 0.933 for MCM2 (p = 0.000) and
0.836 for CDC45 (p = 0.000), indicating that MCM2 and
CDC45 were superior to CDC6 and CDT1, and could be
used as useful tumor markers in diagnosing tongue SCC.
The accuracy of MCM2 with a sensitivity of 94.1% and
specificity of 83.7% was highest, followed by CDC45
(sensitivity of 94.1% and specificity of 74.4%), CDT1
(sensitivity of 76.5% and specificity of 83.7%) and CDC6
(sensitivity of 88.2% and specificity of 63.1%). On the
basis of Multi-ROC analysis, there was a statistically sig-
nificant difference in pair-wise relationship between
MCM2 and CDC6 (p  < 0.01), MCM2 and CDT1 (p  <
0.01), CDC6 and CDC45 (p  < 0.05), and CDT1 and
CDC45 (p < 0.05). However, a statistically significant dif-
ference was not observed between MCM2 and CDC45 (p
> 0.05), or CDC6 and CDT1 (p > 0.05). In other words,
MCM2 and CDC45 had a higher accuracy than CDC6 and
CDT1 for distinguishing precancerous stages from malig-
nant tongue SCC.
Discussion
Alterations in cell cycle regulatory genes that lead to
malignant transformation are one of the main hallmarks
of neoplastic transformation. Logically the initiation of
DNA replication represents a critical prerequisite for accu-
rate cellular proliferation. Proteins that initiate DNA rep-
lication therefore represent excellent candidates as
markers of the tongue squamous cell carcinoma. In this
study, we found that CDC6, CDT1, MCM2 and CDC45
mRNA expression analyzed by quantitative real-time PCR
Relationship between the expression of CDC6 and CDT1  (A), and of CDC45 and MCM2 (B) in dysplasia and tongue  SCC Figure 3
Relationship between the expression of CDC6 and 
CDT1 (A), and of CDC45 and MCM2 (B) in dysplasia 
and tongue SCC. The scatterplots suggested that the rela-
tionship could be modeled as linear. A significant correlation 
was observed (p = 0.013 and P = 0.037 respectively).
Table 3: Relationship between clinicopathological parameters 
and CDC6, CDT1, MCM2 and CDC45 mRNA expression
Relationship CDC6 CDT1 MCM2 CDC45
correlation(r) 0.323 0.498 0.592 0.451
p-value 0.027 0.000 0.000 0.001BMC Cancer 2008, 8:395 http://www.biomedcentral.com/1471-2407/8/395
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are significantly higher in malignant SCC than mild pre-
cancerous epithelial dysplasia, and the expression levels
in general increase with increasing grade of dysplasia.
In this study, the levels of CDC6 and CDT1 mRNA expres-
sion are up-regulated with increasing grade of dysplasia in
SCC and correlate with clinicopathological parameters.
Likewise, the mean level of CDC6 was markedly higher in
SCC of the tongue than in the mild epithelial dysplasia.
Our results showed that the tumor with higher CDC6 and
CDT1 expression revealed more aggressive behavior. To
our knowledge, CDC6 and CDT1 have not been previ-
ously studied in squamous cell carcinoma of the tongue.
A simple linear regression analysis revealed a linear
increase in the level of CDC6 mRNA expression in the
mild, severe and SCC of the tongue, which demonstrated
a linear relationship between increasing CDC6 protein
expression and increasing severity of tongue dysplasia.
Furthermore, our analysis revealed a strong correlation
between CDT1 and CDC6 expression. It is known that
CDT1 and CDC6 are downstream targets of E2F-1 to -3,
which are capable of triggering the transcription of a
reporter gene downstream of the CDC6 and CDT1 pro-
moter [14,15]. Furthermore, transactivation of human
CDC6, CDT1, Geminin and MCM7 is induced by the E2F-
1 to -4 and not by the E2F-5 to -7 transcription factors
[16]. Therefore, overexpression of CDC6 and CDT1 in
SCC of the tongue may be due, at least in part, to an E2F-
1 to -3 mediated effect.
Quantitative real-time PCR analysis showed that MCM2
mRNA expression is significantly higher in tongue SCC
than in epithelia dysplasia. In addition, MCM2 expression
is dependent of the grade of dysplasia, lymph node status
and clinical stage. These observations are in agreement
with previous studies in other tumors. For example,
Kodani et al reported that overexpression of MCM2 was
detected in dysplastic squamous epithelia cells, and the
level increased with the advancement of dysplasia [17].
Similar results were obtained by Todorov et al. who exam-
ined a variety of human tumors and found that MCM2 is
a useful diagnostic and prognostic marker [7].
In our study, a simple linear regression analysis revealed a
highly significant linear relationship between the level of
MCM2 mRNA expression in mild epithelia dysplasia,
severe epithelia dysplasia and malignant tongue SCC.
These findings clearly revealed that MCM2 overexpression
correlated with the severity of dysplasia and associated
with progression of lymph node and clinical stage in
patients with tongue SCC. It may be a useful marker for
evaluating tumor aggressiveness in tongue SCC.
Our results show that CDC45 mRNA is overexpressed in
high grade dysplastic lesions and in tongue SCC. CDC45
overexpression has been reported in many different can-
cer types [18], but few studies have examined changes in
CDC45 expression in the premalignant stage. We believe
that this is the first study to show that CDC45 is fre-
quently overexpressed in oral premalignancy.
Interestingly, a strong association was also established
between MCM2 and CDC45 expression. It is similar to the
relationship of CDC6 and CDT1. Both MCM2 and
CDC45 are regulated by the upstream transcriptional fac-
tors E2F and cyclin D [19,20]. Studies in breast, lung, head
and neck, esophagus, and colon mantle cell lymphoma
found that E2F-1 overexpression is associated with
increased proliferation and aneuploidy, and that cyclin
D1 acts as a positive regulator of the transition from G1-
phase to S phase by association with and activation of
CDKs, leading to uncontrolled growth of tumor cells
[21,22].
In this study, CDC6 expression was obviously lower than
the other three genes. Similar difference in the protein lev-
els of CDC6 and MCM2 was observed in cervical dysplasia
[22]. These results may be, at least in part, resulted from
the rapid turnover of CDC6 mRNA and protein which
normally occurs in the cell.
The QRT-PCR assay described in this paper demonstrates
high diagnostic sensitivity and accuracy. This assay is rela-
tively rapid, technically amendable, and requires only a
small amount of total RNA extracted from formalin-fixed
and paraffin-embedded specimens. Furthermore, QRT-
PCR test has the potential for automation and standardi-
Receiver operating characteristics (ROC) curve of normal- ized expression of CDC6, CDT1, MCM2, and CDC45 Figure 4
Receiver operating characteristics (ROC) curve of 
normalized expression of CDC6, CDT1, MCM2, and 
CDC45. Area under the curve (AUC) of 1.0 represents a 
"perfect" diagnostic test without any false negative or false 
positive results.BMC Cancer 2008, 8:395 http://www.biomedcentral.com/1471-2407/8/395
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zation. Therefore, the assay has potential clinical utility as
a complementary technology to the current pathological
diagnosis methods in distinguishing malignant SCC from
benign dysplasia.
Conclusion
This study shows that mRNA of the replication-initiation
proteins are overexpressed in tongue dysplastic lesions
and SCC and that the higher levels are associated with
lesions that are more likely to progress to tongue SCC.
These proteins are useful diagnostic markers for distin-
guishing malignant from benign epithelial dysplasia and
for early detection and diagnosis of SCC as an adjunct to
clinicopathological parameters.
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